A patented treatment could restore eyesight for millions of sufferers of corneal disease.
The University of Melbourne-led team of researchers have grown corneal cells on a layer of film that can be implanted in the eye to help the cornea heal itself. They have successfully restored vision in animal trials and are aiming to move to human trials in 2017.
Researchers have found that coral reefs may play a key role in cloud formation. Now they’re working to make climate modelling more accurate.
Australian and international scientists, led by QUT’s Professor Zoran Ristovski, spent a month in late 2016 collecting data on airborne particles emitted from the Great Barrier Reef, which they are now analysing.
Across Japan teeth are being made stronger with chewing gum and other products using an ingredient discovered in Australian dairy milk.
Now an innovative Japanese company is taking the Australian discovery to dental surgeries around the world.
“Our discovery was based on milk, to develop a delivery system of calcium phosphate to make teeth stronger,” says Eric Reynolds, from The University of Melbourne.
Clinical trials of the chewing gum showed that it helps stop tooth decay and helps reverse early stages of tooth decay.
“The Recaldent chewing gum was very successful in Japan and the leading dental supply company in Japan, GC Corporation, then became interested in the technology.”
“We’ve developed materials for repair of tooth decay and damage but now we’re focusing on prevention and protection collaborating with Melbourne University,” says Satoshi Tosaki from GC Corporation.
“One of those products is a cream, in Australia it’s called Tooth Mousse, that’s sold to dentists to strengthen patients’ teeth and that’s now sold in more than 50 countries worldwide,” he says.
“I’ve really enjoyed working with GC because I’ve learnt a lot from them in terms of business. But I think the most gratifying thing is that their products actually help people, and substantially reduce the burden of oral disease,” Eric says.
Malaria kills 500,000 people every year. And 90 per cent of those are children. Griffith University researchers are screening hundreds of thousands of compounds supplied by Japanese companies to find the right compound with activity against the malaria parasite.
Japan’s Global Health Innovative Technology Fund is supporting the research as part of their search for new ways to fight malaria.
“GHIT is a fund that invests in partnerships between Japanese and non-Japanese entities,” says BT Slingsby, the Executive Director of GHIT.
“Many of those entities are in Australia including The University of Melbourne, The Walter and Eliza Hall Institute, and Griffith University.”
“Currently we’re working with companies such as Daiichi-Sankyo, Takeda, Mitsubishi Tanabe, and Eisai,” says Griffith University’s Vicky Avery.
They bring those compounds to us. We then dispense them into plates which contain the parasite we’re trying to kill. After they’ve been incubated for a period of time we then look to see whether they’ve had an effect in killing the parasites.
“Once one defines a hit, usually it’s the pharmaceutical company that drives forward the further development of that compound to create a drug.
“This collaboration is fantastic in that it has three groups who complement each other,” Vicky says.
The Japanese pharma companies bring expertise in drug discovery and development. GHIT has managed to pull together significant funding from both global partners as well as the Japanese Government. And Griffith University brings the biology expertise.
A robotic arm is the key to a radical new stroke treatment, helping patients regain upper body movement.
Melbourne researchers have developed a device that helps stroke patients learn to use their bodies again by tracking their movements while performing exercises. The arm movements can be displayed on a computer screen, and the activities turned into a game.
“The patients enjoy using the robot because it’s like playing computer games,” says Associate Professors Denny Oetomo, who is working with Ying Tan, and a team at The University of Melbourne and Royal Melbourne Hospital.
A PhD student at The University of Melbourne has discovered a technique that can improve the resolution of bionic eyes for people who suffer from retinal conditions such age-related macular degeneration and retinitis pigmentosa.
Assessing ageing bridges just got safer and easier, thanks to a high-tech radar device that fits inside a suitcase.
Developed by Dr Lihai Zhang of The University of Melbourne as part of a collaborative research project supported by The Australia-Indonesia Centre, the IBIS-S radar technology can scan a bridge in 15 minutes from a kilometre away with an accuracy of 0.01mm, quickly assessing its condition and stability.